Abstract Details

Title IRX4204: A Clinical Stage, Potent, and Highly Selective RXR Agonist Compound Is Brain Penetrant, and Promotes Differentiation of Oligodendrocyte Precursor Cells (OPCs) In Vitro

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 006

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Martin E. Sanders, MD PRESENTER	No disclosure on file
Satish Medicetty, PhD (Renovo Neural, Inc.)	No disclosure on file
	No disclosure on file
	No disclosure on file